Pharmacy Report Archives - Page 13 of 139 - Becker's Hospital Review

A 200% pharma tariff threat | CVS ordered to pay $949M | Michigan Medicine exec receives ASHP award | Novartis drug fails phase 3 trial | Pharmacy leader-turned-CEO: 7 essentials to future-proof talent

July 9, 2025 1. Trump threatens 200% tariffs on pharmaceuticals Full story 2. CVS' Omnicare hit with $949M judgement in False Claims case Full story 3. Exclusive access to 100+ health system voices — connect, collaborate and lead here. 4.…

Common drug may hinder cancer care | FDA lags in global inspections | After delay, rare disease drug approved | 48 systems with strong finances | Trump's new tariffs: 4 notes

July 8, 2025 1. Drug inspectors warn of slower checks following FDA layoffs Full story 2. Common drug may limit cancer treatment's efficacy: Study Full story 3. From backlog to throughput: How MultiCare added surgical cases with existing resources —…

$5B in missed savings: CMS drug talks changed | Multiple myeloma drug approved | 1st lung injury tied to cancer therapy | 15 fastest-growing cities | Tariffs delayed again

July 7, 2025 1. Big Beautiful Bill narrows CMS drug price negotiation authority Full story 2. 1st case of lung injury tied to specific cancer therapy: 4 notes Full story 3. From supply chain to clinical strategy — see how…

Health system drug expenses soar | 6 drugs in shortage | Tariff deadline looms: 6 notes | Novo Nordisk inks Wegovy partnership | 10 systems seeking pharma leaders

July 3, 2025 1. Median health system margins still at 1%, drug expenses soar Full story 2. 6 drugs in shortage Full story 3. Bon Secours Mercy's infusion access team is reducing delays — see their playbook, here. 4. Tariff…

Pharmacy workforce trends that matter | System drug expenses soar | 5 GLP-1 updates | Teva recalls drug over pill mixup | After strikes, Calif. workers get raises

July 2, 2025 1. What's working in pharmacy workforce transformation Full story 2. Health system margins still at 1%, drug expenses soar Full story 3. See how pharma execs are tackling 2025's biggest issues & what 500+ leaders think is…

Osteoporosis drugs tied to heart risk | AHA backs Tenn. 340B law | FDA updates ADHD extended-release drug labels | Mo. system centralizes med distribution | Supreme Court lets Okla. PBM ruling stand

July 1, 2025 1. AHA backs Tennessee 340B law: 3 notes Full story 2. 3 osteoporosis medications linked to heart attack risk: 5 notes Full story 3. Interoperability just got an upgrade — what to know, here. 4. St. Luke's…

J&J loses part of 340B rebate case | FDA drops REMS for some CAR-T drugs | Hospital pharmacy staffing issues persist | 760 hospitals risk closure | Optum Rx cuts reauthorizations for 60+ drugs

June 30, 2025 1. Federal judge backs HRSA in J&J 340B rebate dispute Full story 2. FDA drops REMS requirement for some CAR-T therapies Full story 3. Exclusive access to 100+ health system voices — connect, collaborate and lead here. 4.…

CVS fined $95M for inflating Medicare drug prices | UK probes link between GLP-1s, acute pancreatitis | 10 systems seeking pharmacy leaders | Iowa businesses sue to block PBM law | FDA drug evaluation head to retire

June 26, 2025 1. CVS Caremark ordered to pay $95M for inflating Medicare drug prices Full story 2. Iowa businesses sue to block new PBM regulation law Full story 3. Missed scripts = missed revenue. What health system leaders say…

Why Geisinger pharmacy is an LLC | Dr. Oz opposes PBM rebates | Bold moves to expand care: 10 pharma execs | Pharmacists' role in inpatient care grows | Systems sharpen digital pharmacy tools

June 25, 2025 1. Why Geisinger spun off its pharmacy — and what it gained Full story 2. Dr. Oz urges PBMs to end drug rebates Full story 3. From supply chain to clinical strategy — see how 500+ pharmacy…

Trump's PBM policy, so far | Cell therapy replaces insulin in small trial | Dupixent receives another approval | Novo Nordisk drops Hims | NM system CEO abruptly resigns

June 24, 2025 1. 10 Type 1 diabetes patients off insulin one year after stem cell therapy: Study Full story 2. The Trump administration's approach to PBMs, so far: 5 things to know Full story 3. Medication access is under…